A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Clinical trial NCT05598268 · UNKNOWN

Trial details

NCT number: NCT05598268
Sponsor: ImmVira Pharma Co. Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Lung Cancer Liver Cancer Lymphoma Mesothelioma of Pleura

Start date: 2022-03-01
Primary completion: 2024-06-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.